India Today TV/Aaj Tak reporter Kumar Abhishek took part in the Phase 3 clinical trials of Bharat BioTech's Covaxin. Abhishek volunteered for the trials in Kanpur and took the first dose of the vaccine shot on December 11. He is scheduled to take the second shot on January 8, following which the trial will be completed. Watch what Kumar Abhishek said about his experience.
